Volume 98, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Congenital toxoplasmosis (CT) results from transplacental passage of to the fetus during acute maternal infection. Our study aims to report clinical and biological patterns of 35 cases of CT diagnosed at the department of the Parasitology of the Pasteur Institute of Tunis and to access the performance of prenatal and early postnatal diagnosis techniques. Serological screening of maternal infection was performed by Immunoglobulin (Ig) M and IgG detection and IgG avidity determination. Prenatal diagnosis was based on both DNA detection in the amniotic fluid and monthly ultrasound examinations. polymerase chain reaction analysis on amniotic fluid, performed only in 15 cases, detected ’s DNA in five cases (33.3%). Ultrasound examination did not reveal any morphological abnormalities. Thirty newborns had serological criteria of infection. Congenital toxoplasmosis diagnosis was confirmed in 23 cases (76.6%) by immunoblot. Among the 35 born-infants, five (14.3%) were symptomatic: three had chorioretinitis at the first clinical ocular examination, one had neurological symptoms (seizures) with positive parasite DNA in cerebral spinal fluid, and one had both ophthalmological and neurological damages— chorioretinitis and intracranial calcifications in the computed tomography scan. Thirty-four of 35 infected children were treated with pyrimethamine–sulfadiazine combination. Four (11.7%) of the treated infants showed abnormal hematological values because of the treatment side effect. Serological rebound was observed in seven infants. A screening program and a diagnostic algorithm in pregnant women should be implemented in Tunisia to improve the follow-up of seronegative ones and to prevent CT cases.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Bessières M-H, Cassaing S, Fillaux J, Berrebi A, , 2008. Toxoplasmose et grossesse. Revue Francophone des Laboratoires 2008: 3950. [Google Scholar]
  2. Bouratbine A, Siala E, Chahed MK, Aoun K, Ben Ismail R, , 2001. Sero-epidemiologic profile of toxoplasmosis in northern Tunisia. Parasite 8: 6166. [Google Scholar]
  3. Sellami H, Amri H, Cheikhrouhou F, Sellami A, Makni F, Trabelsi H, Trabelsi K, Guermazi M, Ayadi A, , 2010. Toxoplasmosis in Sfax, Tunisia. Bull Soc Pathol Exot 103: 3740. [Google Scholar]
  4. Ben Abdallah R, Siala E, Bouafsoun A, Maatoug R, Souissi O, Aoun K, Bouratbine A, , 2013. Toxoplasmosis mother-to-child screening: study of cases followed in the Pasteur Institute of Tunis (2007–2010). Bull Soc Pathol Exot 106: 108112. [Google Scholar]
  5. Bessières M, Berrebi A, Cassaing S, Fillaux J, Cambus J, Berry A, Assouline C, Ayoubi J, Magnaval J, , 2009. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 104: 389392. [Google Scholar]
  6. Robert-Gangneux F, Gavinet M-F, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J, , 1999. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol 37: 28932898. [Google Scholar]
  7. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E, , 2016. Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis 84: 2233. [Google Scholar]
  8. Machado AS, Andrade GM, Januario JN, Fernandes MD, Carneiro AC, Carneiro M, Carellos EV, Romanelli RM, Vasconcelos-Santos DV, Vitor RW, , 2010. IgG and IgM western blot assay for diagnosis of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 105: 757761. [Google Scholar]
  9. Capobiango JD, Monica TC, Ferreira FP, Mitsuka-Bregano R, Navarro IT, Garcia JL, Reiche EM, , 2016. Evaluation of the western blotting method for the diagnosis of congenital toxoplasmosis. J Pediatr (Rio J) 92: 616623. [Google Scholar]
  10. Gilbert R, Thalib L, Tan H, Paul M, Wallon M, Petersen E, , 2007. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 14: 813. [Google Scholar]
  11. Ben Abdallah R, Aoun K, Siala E, Souissi O, Maatoug R, Hlioui S, Bouratbine A, , 2009. Congenital toxoplasmosis: clinical and biological analysis of 11 cases in Tunisia. Arch Pediatr 16: 118121. [Google Scholar]
  12. Pinon JM, 2001. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 39: 22672271. [Google Scholar]
  13. Kieffer F, Thulliez P, Kassis M, Rigourd V, Magny J, , 2009. Prenatal treatment for congenital toxoplasmosis. Arch Pediatr 16: 885887. [Google Scholar]
  14. Cortina-Borja M, European Multicentre Study on Congenital T , 2010. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 7: e1000351. [Google Scholar]
  15. Wallon M, Cozon G, Ecochard R, Lewin P, Peyron F, , 2001. Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur J Pediatr 160: 534540. [Google Scholar]

Data & Media loading...

  • Received : 20 Jul 2017
  • Accepted : 28 Jan 2018
  • Published online : 16 Apr 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error